AWARD-WINNING EUROPEAN MARKET LEADER

RheumaBuddy

EMPOWERING PEOPLE WITH RHEUMATOID ARTHRITIS

To help people with rheumatoid arthritis (RA) feel more in control of their illness, we invited rheumatologists and patient organizations around Europe to Co-Create RheumaBuddy.

Screens from the RheumaBuddy app

The problem 
Those with rheumatoid arthritis face limited community support and difficulty managing their daily symptoms. With a complex condition and a lot to discuss, patients and healthcare providers struggle to fit everything into short appointment times.

The innovation 
A digital therapeutics tool that helps people with RA understand, accept and adjust to life with the disease. This improves their daily life and helps them collaborate with their rheumatologists.

Patients are guided to reflect on personal values and goals. From there, they are supported with evidence-based recommendations to improve their lives and well-being.

This supported self-management tool is inspired by the Act-Commit theory. Our goal is to help people understand the disease and how it affects their body; accept this new phase of life; and commit to daily changes that will improve their quality of life.  

The outcome 
An improved patient experience, better health outcomes and a pan-European collaboration.

Personalized goal-setting and coaching users to be more engaged in their treatment, and the app’s active virtual community helps users feel more supported and empowered.

With a comprehensive record of the patient’s symptoms available to share on the app, healthcare providers are able to spend less time reviewing data and more time directly helping their patients.

The MyTreatment module in RheumaBuddy allows people living with RA to receive education and support in managing their specific medications. Along with tailored medication reminders, MyTreatment helps patients to improve their treatment outcomes, thus reducing the potential for flares.

CO-CREATED In collaboration with

Update! RheumaBuddy has been awarded an EU grant to transform the current app into a next-generation precision-medicine platform using medical, behaviorial and digital biomarkers. This is a pan-European project collaborating with research institutes and data science partners across leading organizations in Rheumatology. Read more here: https://www.damandigital.com/press-release-precision-medicine-squeeze